Satovsky Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$361K Buy
12,856
+148
+1% +$3.94K 0.06% 44
2025
Q4
$316K Buy
12,708
+208
+2% +$5.25K 0.06% 44
2025
Q3
$318K Buy
12,500
+214
+2% +$5.28K 0.06% 45
2025
Q2
$298K Sell
12,286
-445
-3% -$10.4K 0.06% 43
2025
Q1
$323K Buy
12,731
+106
+0.8% +$2.77K 0.07% 36
2024
Q4
$335K Sell
12,625
-814
-6% -$22.1K 0.08% 30
2024
Q3
$389K Buy
13,439
+1,037
+8% +$30.3K 0.09% 29
2024
Q2
$347K Buy
12,402
+285
+2% +$7.85K 0.08% 30
2024
Q1
$336K Buy
12,117
+327
+3% +$9.07K 0.1% 28
2023
Q4
$339K Buy
11,790
+158
+1% +$4.78K 0.11% 29
2023
Q3
$386K Buy
11,632
+81
+0.7% +$2.86K 0.13% 26
2023
Q2
$424K Buy
11,551
+677
+6% +$26.4K 0.14% 25
2023
Q1
$444K Buy
10,874
+109
+1% +$4.71K 0.17% 22
2022
Q4
$552K Buy
10,765
+88
+0.8% +$4.22K 0.23% 20
2022
Q3
$467K Buy
10,677
+92
+0.9% +$4.47K 0.27% 18
2022
Q2
$555K Sell
10,585
-22
-0.2% -$1.12K 0.32% 17
2022
Q1
$549K Buy
10,607
+188
+2% +$9.76K 0.37% 16
2021
Q4
$615K Buy
10,419
+75
+0.7% +$3.72K 0.41% 14
2021
Q3
$445K Buy
10,344
+86
+0.8% +$3.81K 0.33% 13
2021
Q2
$402K Buy
10,258
+103
+1% +$4K 0.31% 14
2021
Q1
$368K Buy
10,155
+168
+2% +$5.96K 0.33% 14
2020
Q4
$368K Buy
+9,987
New +$366K 0.35% 15

Other funds holding PFE

Satovsky Asset Management's PFE Position: Q1 2026 in Review

Satovsky Asset Management increased its Pfizer (PFE) stake by 1.2% in Q1 2026, buying an estimated $3.94K and bringing the position to 12,856 shares worth $361K. The position accounts for 0.06% of the portfolio, ranked #44.

Satovsky Asset Management first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $615K in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Satovsky Asset Management held 12,856 shares of Pfizer worth $361K as of Q1 2026.
  • Satovsky Asset Management bought 148 Pfizer shares in Q1 2026, an estimated $3.94K.
  • Pfizer made up 0.06% of Satovsky Asset Management's portfolio in Q1 2026, its #44 holding.
  • Satovsky Asset Management first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Satovsky Asset Management's Pfizer position peaked at $615K in Q4 2021.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Satovsky Asset Management's 13F filing for Q1 2026, filed 14 May 2026.